Pfizer, Inc. (PFE)

MarkMarcellus (25.97) Submitted: 12/25/06 11:16 PM : Start Price: $23.55 PFE Score: -10.11

Collect the dividend and wait for the inevitable. Big pharma isn't what it used to be, but it doesn't have to be at this price.

Report this Post Replies: 0 | Reply | Permalink

hybridinvestor (56.68) Submitted: 12/08/06 8:47 PM : Start Price: $23.06 PFE Score: -8.03

The recent drop starts to provide a reasonable entry point for this major pharma player with arguably the deepest pockets in the industry to gobble up smaller players to improve and keep the pipeline full. I would be an aggressive accumulator in the...

Report this Post Replies: 0 | Reply | Permalink

empirefool (98.05) Submitted: 6/28/06 12:18 AM : Start Price: $20.93 PFE Score: -12.13

Drugs are out of favor, shareholder friendly management and 4.2% dividend.

Report this Post Replies: 0 | Reply | Permalink

JBouchard (99.74) Submitted: 12/07/06 2:36 PM : Start Price: $22.70 PFE Score: -6.49

As a good play on the aging population in North America, the company seems well-positioned.

I've been following the company for a couple of months, and the bad news wih the failure of torcetrapib (which comes on top of a recent slump on the share pr...

Report this Post Replies: 0 | Reply | Permalink

superquark (61.06) Submitted: 12/04/06 1:05 AM : Start Price: $21.58 PFE Score: 3.15

pfizer just reported discontinued a new cholesterol drug trial because a high number of unexpected deaths - the drug is a new class of medicine to treat hyperlipidemia and was anticipated to a new blockbuster. liptor goes off patent in about 5 years...

Report this Post Replies: 0 | Reply | Permalink

FreethinkerKW (66.67) Submitted: 12/04/06 10:13 AM : Start Price: $21.97 PFE Score: -4.30

STRONG BUY opp here on CAPS and in real life.

We need to get the CAPS system working with dividends and dividend re-investment for a stock such as this Blue Chip.

Report this Post Replies: 2 | Reply | Permalink

dragon1982 (69.32) Submitted: 5/30/07 7:20 PM : Start Price: $25.50 PFE Score: -8.71

low price/book, dividend

Report this Post Replies: 0 | Reply | Permalink

DSWSLP (< 20) Submitted: 1/25/07 7:44 AM : Start Price: $24.48 PFE Score: -11.27

The clinicial trials of torcetrapid were disappointing and concerning but the actual numbers were not so gloomy. My guess is that their research is not comlpeted. In fact they may be setting up themselves politically. In this climate of litigation...

Report this Post Replies: 0 | Reply | Permalink

adrianunderwater (< 20) Submitted: 6/09/07 4:47 AM : Start Price: $24.71 PFE Score: -7.83

Profit margin at 37% ebitda margin at 42%, all with a PE at 10 or so and a dividend yield over 4%... This stays a healthy company. Of course generics are a threat, but then again, which company operates in a 'no threat' situation?? And I expect the c...

Report this Post Replies: 0 | Reply | Permalink

martynanasi (99.41) Submitted: 11/09/06 12:19 PM : Start Price: $24.92 PFE Score: -18.43

Democrats coming in will harm pricing power going forward. I do like the sector itself and think value is there. PFE is not my top pick since their size and organic growth is stalling without acquistions.

Report this Post Replies: 2 | Reply | Permalink